Tuesday, 02 January 2024 12:17 GMT

QRCS Enhances Blood Cancer Diagnostic Services In Syria


(MENAFN- Gulf Times) Qatar Red Crescent Society (QRCS) delivered an advanced flow cytometry machine to the Ministry of Health's (MOH) Pathological Anatomy Laboratory in Idlib, aimed at aiding Syria's specialised health care services.

According to QRCS, this contribution forms part of a project to enhance access, efficiency, and sustainability of specialised health care services in Syria, implemented in co-operation with the Syrian Arab Red Crescent Society (SARCS) and the Idlib Health Directorate.

Being the first of its kind in Syria to provide free-of-charge blood cancer diagnosis services, the machine is the most state-of-the-art in the country, used to analyze cells and diagnose and monitor blood cancers with high accuracy, helping improve chances of early detection and therapy personalisation.

The flow cytometry machine is one of the main advanced medical diagnostic instruments. It is useful in diagnosing blood cancers such as leukemia and lymphoma, by identifying the type and measuring the number of cancer cells. Other uses include monitoring human immunodeficiency virus (HIV) patients, monitoring bone marrow transplants, and assessing autoimmune diseases.

According to the medical team at the Pathological Anatomy Laboratory in Idlib, this machine is a substantial upgrade to laboratory diagnostic services in the governorate.

blade-->

QRCS donates an advanced flow cytometry machine to the Ministry of Health's Pathological Anatomy Laboratory in Idlib.



Since two similar machines available across the country are operated by private profit-seeking hospitals, this leading QRCS initiative will provide a huge humanitarian impact, making advanced diagnosis accessible to all underprivileged patients for free.

This achievement is part of QRCS' ongoing efforts to support the Syrian health system and secure the latest medical technologies to raise the quality of health services and ensure sustainability in serving the most vulnerable groups.

Another cancer-related project to be launched by QRCS seeks to provide chemotherapy and immunotherapy drugs for 100 displaced and poor cancer patients at the oncology centres of Syria, pegged at QR10,000 per patient, or QR1mn in total.

QRCS invites donors to show compassion for Syrians suffering from cancer. By contributing, they remove financial barriers, allowing them to receive the essential medical treatment they urgently need.

Donations can be received via QRCS' website (), mobile app (, home donation collection (33998898), donor service (66666364), call centre (44027777), or donation collection agents at malls and shopping centers.

MENAFN20102025000067011011ID1110218442



Gulf Times

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search